மருந்தியல் எதிர்ப்பு உடல் பருமன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருந்தியல் எதிர்ப்பு உடல் பருமன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருந்தியல் எதிர்ப்பு உடல் பருமன் Today - Breaking & Trending Today

Drug found to be safe and effective for treating patients with obesity and type 2 diabetes

Drug found to be safe and effective for treating patients with obesity and type 2 diabetes
A new study confirms that treatment with Bimagrumab, an antibody that blocks activin type II receptors and stimulates skeletal muscle growth, is safe and effective for treating excess adiposity and metabolic disturbances of adult patients with obesity and type 2 diabetes.
These exciting results suggest that there may be a novel mechanism for achieving weight loss with a profound loss of body fat and an increase in lean mass, along with other metabolic benefits.
Steve Heymsfield, MD, FTOS, Past President of The Obesity Society and Corresponding Author of the Study ....

United States , United Kingdom , Steve Heymsfield , Las Vegas , Emily Henderson , Pennington Biomedical Research Center , Body Composition Laboratory , Obesity Society , Baton Rouge , Pharmacological Anti Obesity , Weight Loss , Body Mass Index , Type 2 Diabetes , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , லாஸ் வேகாஸ் , எமிலி ஹென்டர்சன் , பென்னிங்டன் உயிர் மருத்துவ ஆராய்ச்சி மையம் , உடல் கலவை ஆய்வகம் , உடல் பருமன் சமூகம் , தடியடி ரூஜ் , மருந்தியல் எதிர்ப்பு உடல் பருமன் , நீரிழிவு நோய் , உடல் பருமன் , எடை இழப்பு , உடல் நிறை குறியீட்டு ,

Medication shows promise for weight loss in patients with obesity, diabetes

E-Mail
SILVER SPRING, Md. A new study confirms that treatment with Bimagrumab, an antibody that blocks activin type II receptors and stimulates skeletal muscle growth, is safe and effective for treating excess adiposity and metabolic disturbances of adult patients with obesity and type 2 diabetes.
These exciting results suggest that there may be a novel mechanism for achieving weight loss with a profound loss of body fat and an increase in lean mass, along with other metabolic benefits, said Steve Heymsfield, MD, FTOS, past president of The Obesity Society and corresponding author of the study. Heymsfield is professor and director of the Metabolism and Body Composition Laboratory at the Pennington Biomedical Research Center in Baton Rouge, La. ....

United States , United Kingdom , Abram Miller , Didier Laurent , Therese Swan , Ronenn Roubenoff , Laura Coleman , Las Vegas , Thomas Wade , Robert Perry , Daniel Rooks , Steve Heymsfield , Jens Praestgaard , Bret Goodpaster , Olivier Petricoul , Novartis Institutes For Biomedical Research , Qps Miami Research Associates In , Body Composition Laboratory , Obesity Society , Pennington Biomedical Research Center , Novartis Institutes Of Biomedical Research In Basel , Panax Clinical Research Of Miami , Advent Health Research Institute In Orlando , Baton Rouge , Pharmacological Anti Obesity , Translational Medicine ,